publication date: Dec. 19, 2010

In this issue: 

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

Download (PDF 738KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.